Trial Profile
A trial to find the silent venous thromboembolism in multiple myeloma patients treated with lenalidomide
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Apr 2016
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- 05 Apr 2016 New trial record